Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome - Positive acute lymphoblastic leukemia

O. G. Ottmann, R. A. Larson, H. M. Kantarjian, P. D. Le Coutre, M. Baccarani, A. Hochhaus, D. W. Kim, X. Fan, S. Novick, F. J. Giles

Research output: Contribution to journalLetter

24 Scopus citations
Original languageEnglish (US)
Pages (from-to)1411-1413
Number of pages3
JournalLeukemia
Volume27
Issue number6
DOIs
StatePublished - Jun 1 2013

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Ottmann, O. G., Larson, R. A., Kantarjian, H. M., Le Coutre, P. D., Baccarani, M., Hochhaus, A., Kim, D. W., Fan, X., Novick, S., & Giles, F. J. (2013). Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome - Positive acute lymphoblastic leukemia. Leukemia, 27(6), 1411-1413. https://doi.org/10.1038/leu.2012.324